For example, UBE2C is highly expressed in gastric cancer, and inhibition of UBE2C expression decreases the development of gastric adenocarcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways [35]. The gene discussed is UBE2C; the disease is gastric cancer.